{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:02:57Z","timestamp":1790056977466,"version":"4.0.1"},"reference-count":47,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS\u20102023\u201000265159"],"award-info":[{"award-number":["RS\u20102023\u201000265159"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["movementdisorders.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Movement Disorders"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>\u03b1<\/jats:italic>\n                      \u2010Synuclein aggregation is a pathological hallmark of synucleinopathies, including Parkinson's disease (PD) and multiple system atrophy (MSA). Although pathogenic\n                      <jats:italic>\u03b1<\/jats:italic>\n                      \u2010synuclein seeds can be detected by real\u2010time quaking\u2010induced conversion (RT\u2010QuIC), current assays primarily rely on cerebrospinal fluid, whose invasiveness limits repeated and large\u2010scale applications. We therefore evaluated the feasibility of detecting pathogenic\n                      <jats:italic>\u03b1<\/jats:italic>\n                      \u2010synuclein using urine\u2010derived neuronal extracellular vesicles (NEVs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Urine\u2010derived NEVs were enriched by direct immunoprecipitation using L1CAM\u2010conjugated magnetic beads. The RT\u2010QuIC assay was performed in 26 patients with PD, 13 with MSA, and 25 disease controls, including 16 healthy controls (HC), 4 with progressive supranuclear palsy (PSP), and 5 with normal pressure hydrocephalus (NPH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Urine\u2010derived NEVs exhibited characteristic neuronal and exosomal markers and a typical extracellular vesicle size distribution. The urine\u2010based RT\u2010QuIC assay distinguished PD from disease controls with 73.1% sensitivity and 84% specificity, and MSA from disease controls with 76.9% sensitivity and 84% specificity. When compared with HC alone, sensitivity and specificity were 73.1% and 93.8% for PD, and 76.9% and 93.8% for MSA, respectively. Kinetic analysis showed higher maximum fluorescence intensity and area under the curve (AUC) in PD compared with both disease controls and HC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 in all). MSA also demonstrated higher maximum fluorescence intensity than HC and increased AUC compared with both disease controls and HC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 in all).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We developed and optimized a completely non\u2010invasive urine\u2010derived NEV\n                      <jats:italic>\u03b1<\/jats:italic>\n                      \u2010synuclein RT\u2010QuIC assay that demonstrates high specificity and moderate sensitivity for synucleinopathies. This approach warrants further validation in larger cohorts. \u00a9 2026 International Parkinson and Movement Disorder Society.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/mds.70533","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:30:39Z","timestamp":1790055039000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urine\u2010Derived Neuronal Extracellular Vesicle\n                    <scp>\n                      <i>\u03b1<\/i>\n                    <\/scp>\n                    \u2010Synuclein Seed Amplification Assay for Synucleinopathies: A Non\u2010Invasive Biomarker Study"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9940-8685","authenticated-orcid":false,"given":"Hoang Bao Tram","family":"Tran","sequence":"first","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Department of Medical Sciences Graduate School of Hallym University  Chuncheon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-5566","authenticated-orcid":false,"given":"Huu Dat","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3430-9443","authenticated-orcid":false,"given":"Thanh Trung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Department of Medical Sciences Graduate School of Hallym University  Chuncheon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Joung","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Department of Medical Sciences Graduate School of Hallym University  Chuncheon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk\u2010Jun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Department of Medical Sciences Graduate School of Hallym University  Chuncheon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-7199","authenticated-orcid":false,"given":"In Hee","family":"Kwak","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Hallym Neurological Institute, Hallym University  Anyang Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-8436","authenticated-orcid":false,"given":"Dong Gyun","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Hallym Neurological Institute, Hallym University  Anyang Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hyun","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Hallym Neurological Institute, Hallym University  Anyang Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Kook","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Hallym Neurological Institute, Hallym University  Anyang Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6733-9779","authenticated-orcid":false,"given":"Hyeo\u2010il","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Hallym Neurological Institute, Hallym University  Anyang Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7182-6569","authenticated-orcid":false,"given":"Young Eun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology Hallym University Sacred Heart Hospital, Hallym University  Anyang Republic of Korea"},{"name":"Laboratory of Parkinson's Disease and Neurodegenerative Disease Hallym Institute for Translational Medicine  Anyang Republic of Korea"},{"name":"Hallym Neurological Institute, Hallym University  Anyang Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"6","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-023-02653-2","article-title":"The \u2018\u03b1\u2010synucleinopathy syndicate\u2019: multiple system atrophy and Parkinson's disease","volume":"131","author":"Sian\u2010Hulsmann J","year":"2023","journal-title":"J Neural Transm"},{"issue":"1","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-025-01944-x","article-title":"Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha\u2010synuclein pathology in Parkinson's disease","volume":"13","author":"Otero\u2010Jimenez M","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of synucleinopathies","volume":"16","author":"Koga S","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"2","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.14802\/jmd.24075","article-title":"\u03b1\u2010Synuclein: a promising biomarker for Parkinson's disease and related disorders","volume":"17","author":"Hatano T","year":"2024","journal-title":"J Mov Disord"},{"issue":"10291","key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem BR","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20595","article-title":"The role of exosomes in the diagnosis of Parkinson's disease","volume":"9","author":"Shi Q","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s44328-024-00023-w","article-title":"A same day \u03b1\u2010synuclein RT\u2010QuIC seed amplification assay for synucleinopathy biospecimens","volume":"2","author":"Parveen S","year":"2025","journal-title":"NPJ Biosensing"},{"issue":"1","key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra\u2010sensitive quantitation of disease\u2010associated \u03b1\u2010synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT\u2010QuIC","volume":"6","author":"Groveman BR","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-8820-4_2","volume-title":"Protein Misfolding Diseases: Methods and Protocols","author":"Saijo E","year":"2019"},{"issue":"10","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha\u2010synuclein RT\u2010QuIC in the CSF of patients with alpha\u2010synucleinopathies","volume":"3","author":"Fairfoul G","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mdc3.13710","article-title":"\u03b1\u2010Synuclein seed amplification assays in the diagnosis of synucleinopathies using cerebrospinal fluid\u2014a systematic review and meta\u2010analysis","volume":"10","author":"Grossauer A","year":"2023","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1\u2010synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni T","year":"2024","journal-title":"Lancet Neurol"},{"issue":"2","key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger GU","year":"2024","journal-title":"Lancet Neurol"},{"issue":"1","key":"e_1_2_10_15_1","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-025-02034-8","article-title":"Accurate detection of pathologic \u03b1\u2010synuclein in CSF, skin, olfactory mucosa, and urine with a uniform seeding amplification assay","volume":"13","author":"Bsoul R","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40478-021-01175-w","article-title":"Streamlined alpha\u2010synuclein RT\u2010QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies","volume":"9","author":"Bargar C","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/mds.28242","article-title":"Blinded RT\u2010QuIC analysis of \u03b1\u2010synuclein biomarker in skin tissue from Parkinson's disease patients","volume":"35","author":"Manne S","year":"2020","journal-title":"Mov Disord"},{"issue":"6","key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","article-title":"Propagative \u03b1\u2010synuclein seeds as serum biomarkers for synucleinopathies","volume":"29","author":"Okuzumi A","year":"2023","journal-title":"Nat Med"},{"issue":"3","key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.14802\/jmd.26054","article-title":"Serum neuronal extracellular vesicles for RT\u2010QuIC assay to detect pathological \u03b1\u2010synuclein in synucleinopathies","volume":"19","author":"Choi HJ","year":"2026","journal-title":"J Mov Disord"},{"issue":"4","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","DOI":"10.1002\/dad2.70203","article-title":"Alpha\u2010synuclein seed amplification assay in Lewy body dementia versus Alzheimer's disease","volume":"17","author":"McWilliam OH","year":"2025","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"149620","DOI":"10.1016\/j.bbrc.2024.149620","article-title":"Extracellular vesicles contain filamentous alpha\u2010synuclein and facilitate the propagation of Parkinson's pathology","volume":"703","author":"Ishiguro Y","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"e_1_2_10_22_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-025-01122-9","article-title":"Proteolytic activities of extracellular vesicles attenuate A\u2010synuclein aggregation","volume":"11","author":"Vekrellis K","year":"2025","journal-title":"NPJ Park Dis"},{"issue":"1","key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-023-00372-y","article-title":"\u03b1\u2010Synuclein\u2010carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis","volume":"12","author":"Wang P","year":"2023","journal-title":"Transl Neurodegener"},{"key":"e_1_2_10_24_1","doi-asserted-by":"crossref","unstructured":"Br\u00e1sIC XieY SouthwellAL.Neuron\u2010derived extracellular vesicles in plasma present a potential non\u2010invasive biomarker for Huntingtin protein and RNA assessment in Huntington disease. Cold Spring Harbor Laboratory;2025.","DOI":"10.1101\/2025.07.17.665403"},{"issue":"36","key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"13368","DOI":"10.1073\/pnas.0403453101","article-title":"Identification and proteomic profiling of exosomes in human urine","volume":"101","author":"Pisitkun T","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tips.2025.03.006","article-title":"Monitoring neurodegeneration through brain\u2010derived extracellular vesicles in biofluids","volume":"46","author":"Torrini F","year":"2025","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"e_1_2_10_27_1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aeb0555","article-title":"Glomerular routing of tumor\u2010derived extracellular vesicles substantiates urinary biopsy","volume":"12","author":"Kawaguchi S","year":"2026","journal-title":"Sci Adv"},{"key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2147\/IJN.S492381","article-title":"Isolating astrocyte\u2010derived extracellular vesicles from urine","volume":"20","author":"Xie X\u2010H","year":"2025","journal-title":"Int J Nanomed"},{"issue":"1","key":"e_1_2_10_29_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60619-w","article-title":"Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet\u2010a neglected source for uEVs","volume":"10","author":"Musante L","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning GK","year":"2022","journal-title":"Mov Disord"},{"issue":"6","key":"e_1_2_10_31_1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria","volume":"32","author":"Hoglinger GU","year":"2017","journal-title":"Mov Disord"},{"issue":"12","key":"e_1_2_10_32_1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma RB","year":"2015","journal-title":"Mov Disord"},{"key":"e_1_2_10_33_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107857","article-title":"Prevalence and clinical impact of alpha\u2010synuclein pathology in idiopathic normal pressure hydrocephalus: insights from RT\u2010QuIC assay","volume":"136","author":"Yu JK","year":"2025","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"e_1_2_10_34_1","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-025-00469-6","article-title":"Refining \u03b1\u2010synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy","volume":"14","author":"Wiseman JA","year":"2025","journal-title":"Transl Neurodegener"},{"issue":"1","key":"e_1_2_10_35_1","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-024-00449-2","article-title":"\u03b1\u2010Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation","volume":"13","author":"Kuang Y","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"2","key":"e_1_2_10_36_1","doi-asserted-by":"crossref","DOI":"10.1212\/WN9.0000000000000008","article-title":"Predicting CSF \u03b1\u2010synuclein seed amplification assay status from demographics and clinical data","volume":"1","author":"Venuto CS","year":"2025","journal-title":"Neurol Open Access"},{"key":"e_1_2_10_37_1","doi-asserted-by":"crossref","unstructured":"ChristensonPR JeongH LiM et al.Blood\u2010based Nano\u2010QuIC: Inhibitor\u2010resistant Detection of Seeding Activity in Patients Diagnosed with Parkinson Disease. bioRxiv;2024.https:\/\/doi.org\/10.1101\/2023.08.09.552630.","DOI":"10.1101\/2023.08.09.552630"},{"issue":"9","key":"e_1_2_10_38_1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/NEN.0000000000000233","article-title":"Quantitative real\u2010time quaking\u2010induced conversion allows monitoring of disease\u2010modifying therapy in the urine of prion\u2010infected mice","volume":"74","author":"Shi S","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"13","key":"e_1_2_10_39_1","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3390\/diagnostics13132192","article-title":"Assessment of aggregated and exosome\u2010associated \u03b1\u2010synuclein in brain tissue and cerebrospinal fluid using specific immunoassays","volume":"13","author":"Anagnostou D","year":"2023","journal-title":"Diagnostics"},{"issue":"20","key":"e_1_2_10_40_1","doi-asserted-by":"crossref","first-page":"13647","DOI":"10.1021\/acs.analchem.0c03092","article-title":"Facile impedimetric analysis of neuronal exosome markers in Parkinson's disease diagnostics","volume":"92","author":"Fu Y","year":"2020","journal-title":"Anal Chem"},{"issue":"9","key":"e_1_2_10_41_1","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/brain\/awac115","article-title":"Detection of neuron\u2010derived pathological \u03b1\u2010synuclein in blood","volume":"145","author":"Kluge A","year":"2022","journal-title":"Brain"},{"issue":"5","key":"e_1_2_10_42_1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s13365-018-0695-4","article-title":"Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease","volume":"25","author":"Pulliam L","year":"2019","journal-title":"J Neurovirol"},{"issue":"8","key":"e_1_2_10_43_1","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1007\/s12035-025-04909-2","article-title":"Most L1CAM is not associated with extracellular vesicles in human biofluids and iPSC\u2013derived neurons","volume":"62","author":"Kadam V","year":"2025","journal-title":"Mol Neurobiol"},{"issue":"6","key":"e_1_2_10_44_1","doi-asserted-by":"crossref","first-page":"e12459","DOI":"10.1002\/jev2.12459","article-title":"Single\u2010extracellular vesicle (EV) analyses validate the use of L1 cell adhesion molecule (L1CAM) as a reliable biomarker of neuron\u2010derived EVs","volume":"13","author":"Nogueras\u2010Ortiz CJ","year":"2024","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"e_1_2_10_45_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JPD-202481","article-title":"The \u03b1\u2010synuclein origin and connectome model (SOC model) of Parkinson's disease: explaining motor asymmetry, non\u2010motor phenotypes, and cognitive decline","volume":"11","author":"Borghammer P","year":"2021","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"e_1_2_10_46_1","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/mds.70017","article-title":"Comparison of two \u03b1\u2010synuclein seed amplification assays for discrimination of Parkinson disease and atypical parkinsonism","volume":"40","author":"Rossi M","year":"2025","journal-title":"Mov Disord"},{"issue":"1","key":"e_1_2_10_47_1","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-022-00283-4","article-title":"Alpha\u2010synuclein seeding shows a wide heterogeneity in multiple system atrophy","volume":"11","author":"Martinez\u2010Valbuena I","year":"2022","journal-title":"Transl Neurodegener"},{"issue":"1","key":"e_1_2_10_48_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.27250","article-title":"Elevated \u03b1\u2010synuclein aggregate levels in the urine of patients with isolated REM sleep behavior disorder and Parkinson's disease","volume":"98","author":"M\u00fcller L","year":"2025","journal-title":"Ann Neurol"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.70533","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mds.70533","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.70533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:30:46Z","timestamp":1790055046000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.70533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":47,"alternative-id":["10.1002\/mds.70533"],"URL":"https:\/\/doi.org\/10.1002\/mds.70533","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"2026-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"mds.70533"}}